Matthew Warner

Matthew Warner serves as the Director of Research at Pathfinder Oncology since August 2025, following a role as Associate Director and Principal Scientist at Creyon Bio from July 2022 to August 2025. Prior positions include Clinical Scientist and Scientific Consultant at Cancer Commons, Lead Scientist in Discovery at Vitrisa Therapeutics, and Postdoctoral Research Associate at both Duke University and the University of York. Matthew's academic foundation includes a PhD in Clinical Biochemistry from the University of Cambridge and an Undergraduate Masters in Biochemistry from the University of Bath. Matthew's research experience encompasses drug discovery, biomarker identification, and molecular oncology, with contributions to several clinical trials and the publication of scientific findings.